Last reviewed · How we verify

NCT03616808: THROMBIN

Thromboelastometry-identified Haemostatic Changes in Isolated Traumatic Brain Injury

Completed NA Last updated 6 April 2021
What this trial tests

NA trial testing Thromboelastometry-guided haemostatic treatment in Coagulation Disorder in 142 participants. Completed in 31 December 2020.

Timeline
21 August 2018
Primary endpoint
30 August 2020
31 December 2020

Quick facts

Lead sponsorLithuanian University of Health Sciences
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment142
Start date21 August 2018
Primary completion30 August 2020
Estimated completion31 December 2020
Sites1 location across Lithuania

Drugs / interventions tested

Conditions studied

Sponsor

Lithuanian University of Health Sciences

Who can join

18 and older, any sex, with Coagulation Disorder or Brain Injuries, Traumatic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective open-label case-control study will be performed aiming to assess the utility of thromboelastometry (ROTEM) for identification of hemostatic changes, goal-directed coagulation management, and prognosis of intracranial hemorrhagic injury progression as well as clinical outcome in patients with isolated traumatic brain injury. Patients undergoing craniotomy to treat traumatic brain injury will be enrolled. All patients will undergo standard perioperative coagulation analysis (APTT, PT, INR, fibrinogen levels, platelet count), whereas ROTEM-guided group will additionally be tested with ROTEM. "Cases" will be managed according to a ROTEM-based algorithm, and "Controls" will be treated as usual (based on clinical judging). Comparative analysis of acquired demographic, clinical and laboratory data will be performed. The investigators believe that ROTEM results could provide better insight into perioperative coagulation changes, be beneficial to patient blood management, and result in better outcome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Coagulation Disorder

Currently open trials in the same condition.

Other Lithuanian University of Health Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03616808.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing